FTC Considering Litigation In Lieu Of Divestiture For Drug Chain Mergers
This article was originally published in The Tan Sheet
Executive Summary
The Federal Trade Commission is contemplating using antitrust litigation instead of its traditional strategy of requiring pharmacy chains to divest store locations in a merger, FTC Bureau of Competition Assistant Director of the Office of Policy & Evaluation David Balto told the National Association of Chain Drug Stores.
You may also be interested in...
FTC Public Workshop On Slotting Issues Urged By Senate Committee
A Federal Trade Commission public workshop to discuss the practice of slotting in retail outlets is suggested by the Senate Committee on Small Business in an Oct. 20 letter to the commission.
Drug store sales
OTC sales in community pharmacies are expected to rise 8.3% to $32 bil. in 1999, compared to sales of $29.5 bil. in 1998, NACDS Interim President and CEO Robert Hannan stated at the trade group's pharmacy and managed care forum in San Diego Aug. 29-Sept. 1. Traditional chain pharmacies and mass merchant pharmacies each are expected to make up 32.5% of that total, or $10.4 bil., while supermarket pharmacies contribute 30.9% ($9.9 bil.) and independent outlets add 4.1% ($1.3 bil.). The most growth, 11.1%, is predicted for mass merchant stores. Meanwhile, Rx sales are expected to rise 18% over 1998 levels, totaling $121.6 bil
Internet
White House-appointed working group will examine unlawful conduct involving use of the Internet, according to an executive order published in the Aug. 11 Federal Register. The group will develop recommendations concerning the extent to which existing federal laws provide a sufficient basis for investigation and prosecution of unlawful conduct involving the medium and the extent to which new technology tools, capabilities or legal authorities are necessary for effective investigation and prosecution. The group also will examine the potential for new or existing tools and capabilities to educate users on minimizing and preventing risks from unlawful Internet conduct. The working group, chaired by Attorney General Janet Reno, will present its report and recommendations to the President and Vice President in 120 days. The group includes representatives from FDA, FTC and DEA